Trials / Withdrawn
WithdrawnNCT01684969
Evidence of Haloperidol Absorption After Topical Administration
Topical Haloperidol: Evidence of Absorption After Topical Administration
- Status
- Withdrawn
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Eric E. Prommer · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This will be a blinded study to compare the absorption of topical haloperidol with placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Haloperidol | 0.5 mg iv x one dose |
| DRUG | Placebo | 0.5 mg iv , one dose |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2012-09-13
- Last updated
- 2016-03-17
Source: ClinicalTrials.gov record NCT01684969. Inclusion in this directory is not an endorsement.